Genix Pharmaceuticals Corporation
Genix Pharmaceuticals Corporation
Share · CA37232A1093 (OTC)
Overview
No Price
Closing Price OTC 18.03.2026: 0,01 USD
18.03.2026 20:00
Current Prices from Genix Pharmaceuticals Corporation
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
GENPF
USD
18.03.2026 20:00
0,01 USD
0,00 USD
Company Profile for Genix Pharmaceuticals Corporation Share
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that lowers blood sugar by increasing the muscle, fat, and liver's sensitivity to insulin. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.
AI Analysis of Genix Pharmaceuticals Corporation
Click any analysis below to get instant AI insights from finAgent
Neuste KI Analysen zu Genix Pharmaceuticals Corporation
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.

Unternehmensdaten

Name Genix Pharmaceuticals Corporation
Firma Genix Pharmaceuticals Corporation
Website https://www.genixpharm.com
Heimatbörse OTC UTC
ISIN CA37232A1093
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - Specialty & Generic
CEO Sina Salehi Pirooz
Land Kanada
Währung USD
Mitarbeiter -
Adresse 10022 – 102 Avenue, T8V 0Z7 Vancouver
IPO Datum 2020-02-18

Ticker Symbole

Name Symbol
Over The Counter GENPF
Weitere Aktien
Investoren, die Genix Pharmaceuticals Corporation halten, haben auch folgende Aktien im Depot:
Baron Health Care Fund Retail Shares
Baron Health Care Fund Retail Shares Fonds
EPHIOS SUB.3 23/31 REGS
EPHIOS SUB.3 23/31 REGS Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026